RAADFest 2016 & Human Age-Reversal Research
August 2, 2016
For the first time in medical history, human studies are being designed for the purpose of inducing meaningful reversal of pathological aging processes. Said differently, these clinical trials aim to alter older humans so that they function as much younger individuals.
Even modest success of these studies will result in a paradigm shift that will impart enormous societal benefits, such as sparing Medicare from insolvency. If I were asked even a few years ago if significant human age-reversal research was feasible, I would have said no. Virtually all attempts to slow aging are conducted in the laboratory setting, far removed from delivery to elderly people who have only a few years of life remaining.
To give you an idea of advances happening at prestigious universities, a protein found in the blood of young animals called GDF-11 is inducing systemic rejuvenation effects on bone, muscle, heart, blood vessels, and brains of older animals.
“GDF” stands for “growth differentiating factor”. It functions to “turn on” senescent stem cells, which results in a restoration of youthful structure and function to senile tissues. This same protein (GDF-11) is found in young humans as well as animals.
What follows are video highlights from RAADFest 2016, where Bill Faloon of Age Reversal Therapeutics, Inc. made our first public presentation.